{"transactions":[{"id":718235,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T22:30:17.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":15528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":15528,"derivative":{"exercise_price":28.14,"expiration_date":"2036-06-29","underlying":"Common Stock","underlying_shares":15528},"source":{"system":"sec-edgar","filing":"0001645512-26-000003","document":"form4-07022026_100712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000164551226000003/form4-07022026_100712.xml","form_type":"4"}},{"id":718234,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T22:30:17.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":3553,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon settlement of a restricted stock unit (\"RSU\") grant.  The shares underlying this RSU vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the \"Plan\")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":3553,"source":{"system":"sec-edgar","filing":"0001645512-26-000003","document":"form4-07022026_100712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000164551226000003/form4-07022026_100712.xml","form_type":"4"}},{"id":726174,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-25T22:06:48.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":2324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":2324,"derivative":{"underlying":"Common Stock","underlying_shares":2324},"source":{"system":"sec-edgar","filing":"0001104659-26-077864","document":"tm2619022-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077864/tm2619022-3_4seq1.xml","form_type":"4"}},{"id":726173,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-25T22:06:48.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":3691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":3691,"derivative":{"exercise_price":107.55,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":3691},"source":{"system":"sec-edgar","filing":"0001104659-26-077864","document":"tm2619022-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077864/tm2619022-3_4seq1.xml","form_type":"4"}},{"id":726172,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-25T22:06:48.000Z","date":"2026-06-23","kind":"exercise","planned":false,"acquired":false,"shares":4712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units are fully vested. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units are fully vested. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4712},"source":{"system":"sec-edgar","filing":"0001104659-26-077864","document":"tm2619022-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077864/tm2619022-3_4seq1.xml","form_type":"4"}},{"id":726171,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T22:06:48.000Z","date":"2026-06-23","kind":"exercise","planned":false,"acquired":true,"shares":4712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":11712,"source":{"system":"sec-edgar","filing":"0001104659-26-077864","document":"tm2619022-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077864/tm2619022-3_4seq1.xml","form_type":"4"}},{"id":727394,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-24T20:15:15.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":28.27,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001104659-26-077305","document":"tm2618690-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077305/tm2618690-1_4seq1.xml","form_type":"4"}},{"id":727393,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T20:15:15.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":37000,"price":100.3215,"value":3711895.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on December 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $100.00 to $100.91. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001104659-26-077305","document":"tm2618690-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077305/tm2618690-1_4seq1.xml","form_type":"4"}},{"id":727392,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T20:15:15.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":37000,"price":28.27,"value":1045990.0,"ownership":{"direct":true},"balance_after":44000,"source":{"system":"sec-edgar","filing":"0001104659-26-077305","document":"tm2618690-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465926077305/tm2618690-1_4seq1.xml","form_type":"4"}},{"id":734948,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:07:59.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":5307,"price":11.1,"value":58907.7,"ownership":{"direct":true},"balance_after":86115,"source":{"system":"sec-edgar","filing":"0001628280-26-043875","document":"wk-form4_1781726876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026043875/wk-form4_1781726876.xml","form_type":"4"}},{"id":742146,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-11T20:10:30.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":5307,"price":11.29,"value":59916.03,"ownership":{"direct":true},"balance_after":91422,"source":{"system":"sec-edgar","filing":"0001628280-26-042506","document":"wk-form4_1781208627.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026042506/wk-form4_1781208627.xml","form_type":"4"}},{"id":752815,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T23:47:19.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":15970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":15970,"derivative":{"exercise_price":0,"exercise_date":"2027-06-01","underlying":"Common Stock","underlying_shares":15970},"source":{"system":"sec-edgar","filing":"0001628280-26-040578","document":"wk-form4_1780530436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040578/wk-form4_1780530436.xml","form_type":"4"}},{"id":752814,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-06-03T23:47:19.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":11069,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11069,"derivative":{"exercise_price":10.52,"exercise_date":"2027-06-01","expiration_date":"2036-06-01","underlying":"Common Stock","underlying_shares":11069},"source":{"system":"sec-edgar","filing":"0001628280-26-040578","document":"wk-form4_1780530436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040578/wk-form4_1780530436.xml","form_type":"4"}},{"id":752813,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-03T23:47:19.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":false,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":23077},"source":{"system":"sec-edgar","filing":"0001628280-26-040578","document":"wk-form4_1780530436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040578/wk-form4_1780530436.xml","form_type":"4"}},{"id":752812,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-03T23:47:19.000Z","date":"2026-06-01","kind":"exercise","planned":false,"acquired":true,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":96729,"source":{"system":"sec-edgar","filing":"0001628280-26-040578","document":"wk-form4_1780530436.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026040578/wk-form4_1780530436.xml","form_type":"4"}},{"id":1077670,"issuer":{"id":4816,"kind":"organization","name":"ALUMIS INC.","symbol":"ALMS"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-01T20:05:13.000Z","date":"2025-07-30","kind":"grant","planned":false,"acquired":true,"shares":49800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the first anniversary of the date of grant, provided that the shares will in any case be fully vested on the date of the Issuer's 2026 annual stockholder meeting, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2024 Equity Incentive Plan (the \"Plan\")) through such vesting date and will vest in full upon a Change in Control (as defined in the Plan), subject to the Reporting Person's Continuous Service (as defined in the Plan) through such date."}],"balance_after":49800,"derivative":{"exercise_price":4.1,"expiration_date":"2035-07-29","underlying":"Common Stock","underlying_shares":49800},"source":{"system":"sec-edgar","filing":"0001415889-25-020837","document":"form4-08012025_040809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1847367/000141588925020837/form4-08012025_040809.xml","form_type":"4"}},{"id":1100803,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-26T20:33:39.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":4712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":4712,"derivative":{"underlying":"Common Stock","underlying_shares":4712},"source":{"system":"sec-edgar","filing":"0001104659-25-063068","document":"tm2519230-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465925063068/tm2519230-2_4seq1.xml","form_type":"4"}},{"id":1100802,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T20:33:39.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":7037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":7037,"derivative":{"exercise_price":63.66,"expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":7037},"source":{"system":"sec-edgar","filing":"0001104659-25-063068","document":"tm2519230-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465925063068/tm2519230-2_4seq1.xml","form_type":"4"}},{"id":1103438,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:48:06.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on June 18, 2025. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-25-061704","document":"tm2518591-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465925061704/tm2518591-1_4seq1.xml","form_type":"4"}},{"id":1103437,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-23T20:48:06.000Z","date":"2025-06-18","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001104659-25-061704","document":"tm2518591-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465925061704/tm2518591-1_4seq1.xml","form_type":"4"}},{"id":1125975,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:07:44.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":23077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":23077,"derivative":{"exercise_price":0,"exercise_date":"2026-06-01","underlying":"Common Stock","underlying_shares":23077},"source":{"system":"sec-edgar","filing":"0001077183-25-000127","document":"wk-form4_1748981256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000127/wk-form4_1748981256.xml","form_type":"4"}},{"id":1125974,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2025-06-03T20:07:44.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":16107,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16107,"derivative":{"exercise_price":7.28,"exercise_date":"2026-06-01","expiration_date":"2035-06-01","underlying":"Common Stock","underlying_shares":16107},"source":{"system":"sec-edgar","filing":"0001077183-25-000127","document":"wk-form4_1748981256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000127/wk-form4_1748981256.xml","form_type":"4"}},{"id":1125973,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:07:44.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":false,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-25-000127","document":"wk-form4_1748981256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000127/wk-form4_1748981256.xml","form_type":"4"}},{"id":1125972,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:07:44.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":73652,"source":{"system":"sec-edgar","filing":"0001077183-25-000127","document":"wk-form4_1748981256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000127/wk-form4_1748981256.xml","form_type":"4"}},{"id":1134777,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:04:16.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":89955,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the \"Merger Agreement\") with Alumis, Inc., a Delaware corporation (\"Parent\"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the \"Exchange Ratio\") shares of voting common stock of Parent, par value $0.0001 per share (\"Parent Common Stock\"), and cash in lieu of any fractional shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/36 of the shares subject to the option vested on January 18, 2024, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":0,"derivative":{"exercise_price":7.29,"expiration_date":"2033-12-17","underlying":"Common Stock","underlying_shares":89955},"source":{"system":"sec-edgar","filing":"0001962918-25-000050","document":"wk-form4_1748030649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000196291825000050/wk-form4_1748030649.xml","form_type":"4"}},{"id":1134776,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-05-23T20:04:16.000Z","date":"2025-05-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43680,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On February 6, 2025, ACELYRIN, Inc., a Delaware corporation (the \"Company\"), entered into an Agreement and Plan of Merger (as amended on April 20, 2025, the \"Merger Agreement\") with Alumis, Inc., a Delaware corporation (\"Parent\"), and Arrow Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub\"). Pursuant to the Merger Agreement, on May 21, 2025, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving as a wholly owned subsidiary of Parent. At the effective time of the Merger (the \"Effective Time\"), each share of common stock, par value $0.00001 per share, of the Company issued and outstanding was converted into the right to receive 0.4814 (the \"Exchange Ratio\") shares of voting common stock of Parent, par value $0.0001 per share (\"Parent Common Stock\"), and cash in lieu of any fractional shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time each stock option that was outstanding and unexercised immediately prior to the Effective Time with a per share exercise price of $18.00 or less was assumed by Parent and converted into an option to purchase a number of shares of Parent Common Stock equal to (i) the number of shares subject to the option immediately prior to the Effective Time, multiplied by (ii) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, which stock option shall have an exercise price equal to (i) the per share exercise price for shares subject to the corresponding Company stock option immediately prior to the Effective Time, divided by (ii) the Exchange Ratio, rounded up to the nearest whole cent."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on the earlier of (i) June 7, 2025, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date of the option, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.46,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":43680},"source":{"system":"sec-edgar","filing":"0001962918-25-000050","document":"wk-form4_1748030649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000196291825000050/wk-form4_1748030649.xml","form_type":"4"}},{"id":1154154,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-09T21:26:57.000Z","date":"2025-05-09","kind":"purchase","planned":false,"acquired":true,"shares":7000,"price":8.1392,"value":56974.4,"ownership":{"direct":false,"nature":"Lynn Tetrault Rollover IRA"},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001077183-25-000100","document":"wk-form4_1746826010.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000100/wk-form4_1746826010.xml","form_type":"4"}},{"id":1409399,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":false,"shares":7501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":7501},"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409398,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409397,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":false,"shares":3199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":7501,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":3199},"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409396,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":350,"price":50.5986,"value":17709.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.55 to $50.71. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409395,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":8661,"price":50.2016,"value":434796.0576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $49.54 to $50.50. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3350,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409394,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"sale","planned":true,"acquired":false,"shares":8490,"price":49.048,"value":416417.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $48.53 to $49.52. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":12011,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409393,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":true,"shares":7501,"price":18.99,"value":142443.99,"ownership":{"direct":true},"balance_after":20501,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409392,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-10","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":4.15,"value":41500.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409391,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-09","kind":"sale","planned":true,"acquired":false,"shares":3199,"price":50.0369,"value":160068.0431,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.25. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1409390,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T20:31:34.000Z","date":"2024-09-09","kind":"exercise","planned":true,"acquired":true,"shares":3199,"price":18.99,"value":60749.01,"ownership":{"direct":true},"balance_after":6199,"source":{"system":"sec-edgar","filing":"0001104659-24-098944","document":"tm2423816-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924098944/tm2423816-2_4seq1.xml","form_type":"4"}},{"id":1420568,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-28T20:31:00.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":false,"shares":4300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":10700,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":4300},"source":{"system":"sec-edgar","filing":"0001104659-24-094012","document":"tm2422915-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924094012/tm2422915-2_4seq1.xml","form_type":"4"}},{"id":1420567,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:31:00.000Z","date":"2024-08-26","kind":"sale","planned":true,"acquired":false,"shares":4300,"price":50.0067,"value":215028.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.03. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-094012","document":"tm2422915-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924094012/tm2422915-2_4seq1.xml","form_type":"4"}},{"id":1420566,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-28T20:31:00.000Z","date":"2024-08-26","kind":"exercise","planned":true,"acquired":true,"shares":4300,"price":18.99,"value":81657.0,"ownership":{"direct":true},"balance_after":7300,"source":{"system":"sec-edgar","filing":"0001104659-24-094012","document":"tm2422915-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924094012/tm2422915-2_4seq1.xml","form_type":"4"}},{"id":1433326,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-14T20:15:12.000Z","date":"2024-08-12","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested and exercisable."}],"balance_after":10000,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-089634","document":"tm2421587-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924089634/tm2421587-2_4seq1.xml","form_type":"4"}},{"id":1433325,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:15:12.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":407,"price":45.3717,"value":18466.2819,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $45.35 to $45.61. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-089634","document":"tm2421587-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924089634/tm2421587-2_4seq1.xml","form_type":"4"}},{"id":1433324,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:15:12.000Z","date":"2024-08-12","kind":"sale","planned":true,"acquired":false,"shares":9593,"price":44.6154,"value":427995.5322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 13, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $44.32 to $45.19. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote."}],"balance_after":3407,"source":{"system":"sec-edgar","filing":"0001104659-24-089634","document":"tm2421587-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924089634/tm2421587-2_4seq1.xml","form_type":"4"}},{"id":1433323,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T20:15:12.000Z","date":"2024-08-12","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":4.15,"value":41500.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001104659-24-089634","document":"tm2421587-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924089634/tm2421587-2_4seq1.xml","form_type":"4"}},{"id":1435189,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-08-13T20:37:27.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":false,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-24-000135","document":"wk-form4_1723581438.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000135/wk-form4_1723581438.xml","form_type":"4"}},{"id":1435188,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:37:27.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":61398,"source":{"system":"sec-edgar","filing":"0001077183-24-000135","document":"wk-form4_1723581438.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000135/wk-form4_1723581438.xml","form_type":"4"}},{"id":1469308,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T20:38:44.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-24-074768","document":"tm2418139-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924074768/tm2418139-4_4seq1.xml","form_type":"4"}},{"id":1469307,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T20:38:44.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":3000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-24-074768","document":"tm2418139-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924074768/tm2418139-4_4seq1.xml","form_type":"4"}},{"id":1472760,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-21T01:47:34.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-24-073638","document":"tm2417588-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924073638/tm2417588-7_4seq1.xml","form_type":"4"}},{"id":1472759,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T01:47:34.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 18, 2025 or (ii) the date of the Issuer's annual meeting of the stockholders to be held in 2025, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":41.39,"expiration_date":"2034-06-17","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-24-073638","document":"tm2417588-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465924073638/tm2417588-7_4seq1.xml","form_type":"4"}},{"id":1482959,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2024-06-11T23:04:55.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":43680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on the earlier of (i) June 7, 2025, or (ii) the day immediately preceding the next annual meeting of stockholders following the grant date of the option, subject to the Reporting Person's continued service as a director through the vesting date."}],"balance_after":43680,"derivative":{"exercise_price":4.46,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":43680},"source":{"system":"sec-edgar","filing":"0001962918-24-000085","document":"wk-form4_1718147088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000196291824000085/wk-form4_1718147088.xml","form_type":"4"}},{"id":1493345,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-04T20:10:34.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":12254,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-24-000096","document":"wk-form4_1717531825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000096/wk-form4_1717531825.xml","form_type":"4"}},{"id":1493344,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2024-06-04T20:10:34.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":8672,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8672,"derivative":{"exercise_price":13.71,"exercise_date":"2025-06-01","expiration_date":"2034-06-01","underlying":"Common Stock","underlying_shares":8672},"source":{"system":"sec-edgar","filing":"0001077183-24-000096","document":"wk-form4_1717531825.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000096/wk-form4_1717531825.xml","form_type":"4"}},{"id":1592506,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T21:26:13.000Z","date":"2024-03-04","kind":"sale","planned":true,"acquired":false,"shares":6112,"price":15.9651,"value":97578.6912,"ownership":{"direct":true},"balance_after":50062,"source":{"system":"sec-edgar","filing":"0001077183-24-000034","document":"wk-form4_1709760358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000034/wk-form4_1709760358.xml","form_type":"4"}},{"id":1703116,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2023-12-20T22:53:56.000Z","date":"2023-12-18","kind":"grant","planned":false,"acquired":true,"shares":89955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36 of the shares subject to the option vest on January 18, 2024, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"1/36 of the shares subject to the option vest on January 18, 2024, and 1/36 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":89955,"derivative":{"exercise_price":7.29,"expiration_date":"2033-12-17","underlying":"Common Stock","underlying_shares":89955},"source":{"system":"sec-edgar","filing":"0001209191-23-059383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000120919123059383/doc4.xml","form_type":"4"}},{"id":1809003,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-14T21:37:27.000Z","date":"2023-08-10","kind":"grant","planned":true,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":11336,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-23-000116","document":"wk-form4_1692049037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000116/wk-form4_1692049037.xml","form_type":"4"}},{"id":1809002,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2023-08-14T21:37:27.000Z","date":"2023-08-10","kind":"grant","planned":true,"acquired":true,"shares":8353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8353,"derivative":{"exercise_price":14.82,"exercise_date":"2024-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":8353},"source":{"system":"sec-edgar","filing":"0001077183-23-000116","document":"wk-form4_1692049037.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000116/wk-form4_1692049037.xml","form_type":"4"}},{"id":1844855,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-23T20:32:01.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-23-074299","document":"tm2319485-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465923074299/tm2319485-5_4seq1.xml","form_type":"4"}},{"id":1844854,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:32:01.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 21, 2024 or (ii) the date of the Issuer's next annual meeting of the stockholders, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":14000,"derivative":{"exercise_price":18.47,"expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-23-074299","document":"tm2319485-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465923074299/tm2319485-5_4seq1.xml","form_type":"4"}},{"id":1880184,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-24T21:29:21.000Z","date":"2023-05-22","kind":"exercise","planned":false,"acquired":false,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":11.6,"exercise_date":"2019-06-01","expiration_date":"2023-06-01","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001077183-23-000064","document":"wf-form4_168496374962456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000064/wf-form4_168496374962456.xml","form_type":"4"}},{"id":1880183,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-24T21:29:21.000Z","date":"2023-05-22","kind":"exercise","planned":false,"acquired":true,"shares":1507,"price":11.6,"value":17481.2,"ownership":{"direct":true},"balance_after":56174,"source":{"system":"sec-edgar","filing":"0001077183-23-000064","document":"wf-form4_168496374962456.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000064/wf-form4_168496374962456.xml","form_type":"4"}},{"id":2233086,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T00:41:07.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":13882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13882,"derivative":{"exercise_price":8.1,"exercise_date":"2023-06-10","expiration_date":"2029-06-10","underlying":"Common Stock","underlying_shares":13882},"source":{"system":"sec-edgar","filing":"0001077183-22-000107","document":"wf-form4_165525365169698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000107/wf-form4_165525365169698.xml","form_type":"4"}},{"id":2233085,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-15T00:41:07.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":15556,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54667,"source":{"system":"sec-edgar","filing":"0001077183-22-000107","document":"wf-form4_165525365169698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000107/wf-form4_165525365169698.xml","form_type":"4"}},{"id":2235309,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:07:52.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 8, 2023 or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":20000,"derivative":{"exercise_price":4.15,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-070114","document":"tm2218129-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465922070114/tm2218129-4_4seq1.xml","form_type":"4"}},{"id":2262394,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-20T21:08:42.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 25, 2017, Lynn Tetrault was granted 10,000 stock options.  The options vest ratably on the next three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":7.27,"expiration_date":"2022-05-25","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001077183-22-000087","document":"wf-form4_165308090690889.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000087/wf-form4_165308090690889.xml","form_type":"4"}},{"id":2262393,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T21:08:42.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":3334,"price":7.27,"value":24238.18,"ownership":{"direct":true},"balance_after":39111,"source":{"system":"sec-edgar","filing":"0001077183-22-000087","document":"wf-form4_165308090690889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718322000087/wf-form4_165308090690889.xml","form_type":"4"}},{"id":2543804,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-13T21:04:44.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":972,"derivative":{"exercise_price":41.76,"exercise_date":"2022-10-11","expiration_date":"2028-10-11","underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001077183-21-000227","document":"wf-form4_163415907002611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000227/wf-form4_163415907002611.xml","form_type":"4"}},{"id":2543803,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-13T21:04:44.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":838,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35777,"source":{"system":"sec-edgar","filing":"0001077183-21-000227","document":"wf-form4_163415907002611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000227/wf-form4_163415907002611.xml","form_type":"4"}},{"id":2670678,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T21:07:55.000Z","date":"2021-06-11","kind":"exercise","acquired":false,"shares":1389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 28, 2016, Lynn Tetrault was granted 8,333 stock options.  The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":9.11,"expiration_date":"2021-07-28","underlying":"Common Stock","underlying_shares":1389},"source":{"system":"sec-edgar","filing":"0001077183-21-000168","document":"wf-form4_162370485942931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000168/wf-form4_162370485942931.xml","form_type":"4"}},{"id":2670677,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-14T21:07:55.000Z","date":"2021-06-11","kind":"exercise","acquired":true,"shares":1389,"price":9.11,"value":12653.79,"ownership":{"direct":true},"balance_after":34939,"source":{"system":"sec-edgar","filing":"0001077183-21-000168","document":"wf-form4_162370485942931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000168/wf-form4_162370485942931.xml","form_type":"4"}},{"id":2671289,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T20:06:54.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options fully vest upon the earlier of (i) June 9, 2022 or (ii) the date of the Issuer's next annual meeting of the stockholders."}],"balance_after":15000,"derivative":{"exercise_price":18.99,"expiration_date":"2031-06-08","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-080109","document":"tm2119501-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465921080109/tm2119501-6_4seq1.xml","form_type":"4"}},{"id":2681536,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T23:57:39.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3714,"derivative":{"exercise_price":40.9,"exercise_date":"2022-06-02","expiration_date":"2028-06-02","underlying":"Common Stock","underlying_shares":3714},"source":{"system":"sec-edgar","filing":"0001077183-21-000158","document":"wf-form4_162285104607570.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000158/wf-form4_162285104607570.xml","form_type":"4"}},{"id":2681535,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T23:57:39.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":3081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Since the date of the reporting person's last report, Ms. Tetrault transferred 13,882 shares of NEO common stock to a former indirect beneficial owner pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the former indirect beneficial owner."}],"balance_after":33550,"source":{"system":"sec-edgar","filing":"0001077183-21-000158","document":"wf-form4_162285104607570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718321000158/wf-form4_162285104607570.xml","form_type":"4"}},{"id":2948050,"issuer":{"id":3693,"kind":"organization","name":"RHYTHM PHARMACEUTICALS, INC.","symbol":"RYTM"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-11T21:11:48.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the options will vest on each one-year anniversary of the grant date, with the first one-third vesting on December 9, 2021."}],"balance_after":37000,"derivative":{"exercise_price":28.27,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0001104659-20-134779","document":"tm2038260-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1645512/000110465920134779/tm2038260-4_4seq1.xml","form_type":"4"}},{"id":3129500,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-01T22:57:38.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":3448,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3448,"derivative":{"exercise_price":28.54,"exercise_date":"2021-05-28","expiration_date":"2027-05-28","underlying":"Common Stock","underlying_shares":3448},"source":{"system":"sec-edgar","filing":"0001077183-20-000133","document":"wf-form4_159105224012827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000133/wf-form4_159105224012827.xml","form_type":"4"}},{"id":3129499,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T22:57:38.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":2698,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44351,"source":{"system":"sec-edgar","filing":"0001077183-20-000133","document":"wf-form4_159105224012827.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718320000133/wf-form4_159105224012827.xml","form_type":"4"}},{"id":3496125,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-06-11T01:19:54.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":4269,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4269,"derivative":{"exercise_price":22.52,"exercise_date":"2020-06-06","expiration_date":"2026-06-06","underlying":"Common Stock","underlying_shares":4269},"source":{"system":"sec-edgar","filing":"0001077183-19-000112","document":"wf-form4_156021597883749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000112/wf-form4_156021597883749.xml","form_type":"4"}},{"id":3496124,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-11T01:19:54.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":3419,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41653,"source":{"system":"sec-edgar","filing":"0001077183-19-000112","document":"wf-form4_156021597883749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718319000112/wf-form4_156021597883749.xml","form_type":"4"}},{"id":3755284,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T18:33:04.000Z","date":"2018-11-19","kind":"sale","acquired":false,"shares":2000,"price":15.97,"value":31940.0,"ownership":{"direct":true},"balance_after":38234,"source":{"system":"sec-edgar","filing":"0001077183-18-000121","document":"wf-form4_154282516716166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000121/wf-form4_154282516716166.xml","form_type":"4"}},{"id":3755283,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T18:33:04.000Z","date":"2018-11-19","kind":"sale","acquired":false,"shares":11000,"price":16,"value":176000.0,"ownership":{"direct":true},"balance_after":40234,"source":{"system":"sec-edgar","filing":"0001077183-18-000121","document":"wf-form4_154282516716166.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000121/wf-form4_154282516716166.xml","form_type":"4"}},{"id":3761841,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 25, 2017, Lynn Tetrault was granted 10,000 stock options.  The options vest ratably on the next three anniversary dates of the grant date."}],"balance_after":6667,"derivative":{"exercise_price":7.27,"exercise_date":"2018-05-25","expiration_date":"2022-05-25","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3761840,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 28, 2016, Lynn Tetrault was granted 8,333 stock options.  The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":2778,"derivative":{"exercise_price":9.11,"exercise_date":"2017-07-28","expiration_date":"2021-07-28","underlying":"Common Stock","underlying_shares":5555},"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3761839,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-15","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 15, 2015, Lynn Tetrault was granted 10,000 stock options.  The options vest ratably on the next three anniversary dates of the grant date."}],"balance_after":0,"derivative":{"exercise_price":6.66,"exercise_date":"2016-07-15","expiration_date":"2020-07-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3761838,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-14","kind":"sale","acquired":false,"shares":5000,"price":16.16,"value":80800.0,"ownership":{"direct":true},"balance_after":51234,"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3761837,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":3333,"price":7.27,"value":24230.91,"ownership":{"direct":true},"balance_after":56234,"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3761836,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":5555,"price":9.11,"value":50606.05,"ownership":{"direct":true},"balance_after":52901,"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3761835,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-16T22:18:12.000Z","date":"2018-11-15","kind":"exercise","acquired":true,"shares":10000,"price":6.66,"value":66600.0,"ownership":{"direct":true},"balance_after":47346,"source":{"system":"sec-edgar","filing":"0001077183-18-000119","document":"wf-form4_154240667556312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000119/wf-form4_154240667556312.xml","form_type":"4"}},{"id":3906222,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:50:47.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":3017,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3017,"derivative":{"exercise_price":11.6,"exercise_date":"2019-06-01","expiration_date":"2023-06-01","underlying":"Common Stock","underlying_shares":3017},"source":{"system":"sec-edgar","filing":"0001077183-18-000047","document":"wf-form4_152823543078587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000047/wf-form4_152823543078587.xml","form_type":"4"}},{"id":3906221,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-05T21:50:47.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":15564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37346,"source":{"system":"sec-edgar","filing":"0001077183-18-000047","document":"wf-form4_152823543078587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718318000047/wf-form4_152823543078587.xml","form_type":"4"}},{"id":4301784,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2017-05-31T01:30:20.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":8667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date."}],"balance_after":8667,"derivative":{"exercise_date":"2017-06-30","underlying":"Common Stock","underlying_shares":8667},"source":{"system":"sec-edgar","filing":"0001209191-17-036319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036319/doc4.xml","form_type":"4"}},{"id":4301783,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-31T01:30:20.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":10000,"price":7.27,"value":72700.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On May 25, 2017, Lynn Tetrault was granted 10,000 stock options.  The options vest ratably on the next three anniversary dates of the grant date."}],"balance_after":10000,"derivative":{"exercise_price":7.27,"exercise_date":"2018-05-25","expiration_date":"2022-05-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-036319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036319/doc4.xml","form_type":"4"}},{"id":4301782,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2017-05-31T01:30:20.000Z","date":"2017-05-30","kind":"exercise","acquired":false,"shares":5072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1,690.6 shares will vest on September 30, 2016 and thereafter, 1,690.7 shares will vest on the last day of each calendar quarter for the next two fiscal quarters up to March 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2016-09-30","expiration_date":"2017-03-31","underlying":"Common Stock","underlying_shares":5072},"source":{"system":"sec-edgar","filing":"0001209191-17-036319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036319/doc4.xml","form_type":"4"}},{"id":4301781,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock","published_at":"2017-05-31T01:30:20.000Z","date":"2017-05-30","kind":"exercise","acquired":false,"shares":2150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Restricted stock has vested and restricted stock certificate issued for shares of the company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"537.5 shares will vest on June 30, 2016 and thereafter, 537.5 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2016-06-30","expiration_date":"2017-03-31","underlying":"Common Stock","underlying_shares":2150},"source":{"system":"sec-edgar","filing":"0001209191-17-036319","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036319/doc4.xml","form_type":"4"}},{"id":4301780,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":32936,"kind":"person","name":"TETRAULT LYNN A.","position":1,"cik":"0001645512","reported_name":"TETRAULT LYNN A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T01:30:20.000Z","date":"2017-05-30","kind":"exercise","acquired":true,"shares":7222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":21782,"source":{"system":"sec-edgar","filing":"0001209191-17-036319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000120919117036319/doc4.xml","form_type":"4"}}]}